Apellis Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 251 67 75 397 710
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% -73.4% 13.3% 425.8% 79.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% 90.0% 92.2% 92.5% 84.8% 83.4%
EBIT (mln) -4 -11 -47 -27 -51 -128 -288 -214 -536 -595 -517 -236
EBIT Δ r/r 0.0% 180.3% 312.4% -41.4% 86.1% 152.0% 125.1% -25.8% 150.9% 10.9% -13.0% -54.3%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -85.3% -805.7% -788.4% -130.4% -33.3%
Koszty finansowe (mln) 0 0 0 0 -0 3 5 30 13 33 30 40
EBITDA (mln) -4 -11 6 -27 -51 -125 -283 -209 -533 -584 -515 -236
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -83.6% -800.8% -775.0% -130.0% -33.3%
Podatek (mln) 0 -0 -27 0 0 -1 5 2 0 1 2 1
Zysk Netto (mln) -4 -11 -47 -27 -51 -128 -310 -345 -746 -652 -529 -198
Zysk netto Δ r/r 0.0% 172.3% 331.2% -41.7% 88.0% 150.0% 143.0% 11.3% 116.4% -12.6% -18.9% -62.6%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -137.6% -1121.3% -864.7% -133.3% -27.9%
EPS -0.22 -0.6 -2.57 -1.5 -3.68 -2.34 -4.98 -4.59 -8.84 -6.15 -4.45 -1.6
EPS (rozwodnione) -0.22 -0.6 -2.57 -1.5 -3.68 -2.34 -4.98 -4.59 -8.84 -6.15 -4.45 -1.6
Ilośc akcji (mln) 18 18 18 18 14 54 62 75 84 106 119 124
Ważona ilośc akcji (mln) 18 18 18 18 14 54 62 75 84 106 119 124
Waluta USD USD USD USD USD USD USD USD USD USD USD USD